Incidence of and Risk Factors for Keratinocyte Carcinoma After Pediatric Solid Organ Transplant. The lead author, Muskaan Sachdeva, MD, a first-year resident at the University of Toronto, discusses the findings of a collaborative study that identifies the risk factors for and the incidence of keratinocyte carcinoma among patients who underwent solid organ transplant during childhood compared with the general population in Ontario, Canada.
Webinar: Diagnosing and Treating Ectodermal Dysplasias
The National Foundation for Ectodermal Dysplasias (NFED) welcomes you to attend this webinar to hear an overview of the ectodermal dysplasias, the associated dermatological manifestations, the importance of patient advocacy groups and understand the struggles of living with ectodermal dysplasias through a patient presentation.
Diagnosing and Treating Ectodermal Dysplasias: Dermatological Manifestations of Ectodermal Dysplasias and Patient Case Presentation
Guest Speaker: Elaine Siegfried, MD
Elaine Siegfried, MD
Dr. Siegfried is the Director of Pediatric Dermatology at SSM Cardinal Glennon Children’s Medical Center. She is also a Professor of Pediatrics and Dermatology at Saint Louis University School of Medicine.
Webinar: Care of Congenital Melanocytic Nevi in Newborns and Infants
Care of Congenital Melanocytic Nevi in Newborns and Infants
Marla Jahnke, MD discusses the findings of her most recent collaborative study – Care of Congenital Melanocytic Nevi (CMN) in Newborns and Infants: Review and Management Recommendations. Learn more about the current state of knowledge around CMN care and monitoring and recommendations for future guidelines.
Marla Jahnke, MD
Dr. Jahnke is a pediatric dermatologist at Henry Ford Health.
Webinar: Reviewing and Publishing – Making an Impact in Pediatric Dermatology
Co-editors of Pediatric Dermatology, Lionel Bercovitch, MD, and Andrea Zaenglein, MD, and chair of PeDRA’s Outcomes Committee, Carrie Coughlin, MD, MPHS, offer guidance to reviewers on how to evaluate a manuscript and advice to authors on preparing a strong manuscript for submission. These skill-sets are not only important for career success, but they help make a positive impact in the field of pediatric dermatology.
Presented in partnership with the SPD Junior Faculty and Fellows Committee.
Reviewing and Publishing – Making an Impact in Pediatric Dermatology
Recorded Live – Wednesday, June 8, 2022, at 5:30 PM PT / 8:30 PM ET
Andrea Zaenglein, MD
Professor of Dermatology and Pediatric Dermatology at Penn State Health
Co-Editor of Pediatric Dermatology
Lionel Bercovitch, MD
Director, Pediatric Dermatology, Professor of Dermatology at Brown University
Co-Editor of Pediatric Dermatology
Carrie C. Coughlin, MD, MPHS
Assistant Professor, Dermatology and Pediatrics, Director – Section of Pediatric Dermatology, Director – Pediatric Dermatology Fellowship at Washington University School of Medicine
Chair, PeDRA Outcomes Committee
New Advances in the Treatment of Atopic Dermatitis in Children
Treatments for moderate-to-severe atopic dermatitis in children have made huge strides in recent months. Listen to Lawrence Eichenfield, MD, Emma Guttman-Yassky, MD, PhD, Candrice Heath, MD, and Minnelly Luu, MD discuss these advancements, what they mean for patients, and the importance of present and future research. This is a follow-up podcast to the Emerging Therapies in the Treatment of Moderate-to-Severe Atopic Dermatitis in Children educational series that aired in 2020.
Lawrence Eichenfield, MD
Professor of Dermatology and Pediatrics
Chief, Pediatric and Adolescent Dermatology
Vice Chair, Department of Dermatology
University of California, San Diego and Rady Children’s Hospital, San Diego
Emma Guttman-Yassky, MD, PhD
Vice Chair for Research
Chair of the Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
Candrice Heath, MD
Bio coming soon
Minnelly Luu, MD
Associate Professor of Clinical Dermatology at the Keck School of Medicine
Co-Director of the Vascular Anomalies Center
Co-Chair for PeDRA Atopic Dermatitis/Psoriasis Focused Study Group
PeDRA Session at SID
Use #PeDRAatSID2022 to showcase PeDRA research, PeDRA members, and more!
PeDRA staff had the opportunity to attend the 2022 SID Meeting in Portland, Oregon last month. The meeting was full of incredible presentations, abstracts, and groundbreaking science. While there, PeDRA conducted a series of short interviews with attendees and presenters like John Harris, MD, PhD, Joel Gelfand, MD, MSCE, FAAD, and PeDRA’s own, Dawn Siegel, MD to capture some exciting meeting highlights.
Hosted by Carrie Coughlin, MD, MPHS from Washington University School of Medicine, and Amy Paller, MD, MS from Northwestern University, this session featured keynote speaker John Harris, MD, PhD from the University of Massachusetts Medical School, presentations from selected abstracts.
PeDRA Session at the 2022 Society for Investigative Dermatology Annual Meeting
Friday, May 20, 2022 at 7:00a – 8:30a PT
Oregon Convention Center (C123-C124).
Hosts: Carrie Coughlin, MD, MPHS and Amy Paller MD, MS
Keynote Speaker: John Harris, MD, PhD
Carrie Coughlin, MD, MPHS
Dr. Coughlin is the Director of the Section of Pediatric Dermatology and Assistant Professor of Dermatology at Washington University School of Medicine in St. Louis and St. Louis Children’s Hospital. Her practice is general pediatric dermatology, but she specializes in treating patients with pigmented skin lesions and immunosuppressed patients. She directs the Pediatric Melanoma and Nevus Clinic, part of Siteman Kids at St. Louis Children’s Hospital. She also holds a joint clinic with pediatric neuro-oncology caring for children with skin eruptions due to cancer therapies. She is Chair of the Skin Tumors and Reactions to Cancer therapies research group and the Outcomes Committee for the Pediatric Dermatology Research Alliance. She is the Treasurer for the International immunosuppression and Transplant Skin Cancer Collaborative. She enjoys leading an Art and Medicine class for first year medical students.
John Harris, MD, PhD
Dr. Harris is Chair of Dermatology, Director of the Autoimmune Therapeutics Institute, and Director of the Vitiligo Clinic and Research Center at UMass Medical School. He is a dermatologist and physician-scientist, caring for patients in a vitiligo specialty clinic and running a research laboratory focused on understanding disease pathogenesis and developing new treatments. His group integrates basic, translational, and clinical research strategies to accomplish this. As a result, early clinical trials in vitiligo have shown success. Dr. Harris founded Villaris Therapeutics, whose focus is to develop an effective, long-lasting treatment for vitiligo, as well as NIRA Biosciences, Aldena Therapeutics, and Vimela Therapeutics, companies focused on inflammatory skin diseases.
Amy Paller, MD, MS
Dr. Paller is the Walter J. Hamlin Professor and Chair of Dermatology, Professor of Pediatrics, and Principal Investigator of the NIH-funded Skin Biology and Diseases Resource-based Center (SBDRC) at Northwestern. She served as Chief of Pediatric Dermatology at Northwestern’s Children’s Hospital until she became Chair of Dermatology at Northwestern in 2004. An author of more than 500 peer-reviewed publications, Dr. Paller has also edited several major textbooks in dermatology, among them Hurwitz’s Clinical Pediatric Dermatology (now 6th edition) and Fitzpatrick’s Dermatology in General Medicine. She is an NIH-funded investigator in both her laboratory-based and clinical research. She has directed the Pediatric Dermatology Clinical Trials Unit at Northwestern/ Lurie Children’s for the past 30 years and has been the lead investigator on several landmark trials in pediatric skin disease, particularly related to atopic dermatitis (AD), psoriasis, and genodermatoses. Her laboratory focuses on skin innervation in inflammatory diseases, wound healing, and topically delivered gene regulation through nanotherapy. She has defined skin and blood biomarkers for children with AD and ichthyoses towards pathogenesis-directed therapy and has developed new patient-related outcomes scales for itch and stigma in children. Dr. Paller was the inaugural President of the International Eczema Council and inaugural co-President of the Pediatric Dermatology Research Alliance. She has been President of the Society for Investigative Dermatology, Society for Pediatric Dermatology, and the Women’s Dermatologic Society. She is currently President of the International Society for Pediatric Dermatology. She has served on Council and the Board of Scientific Councilors for NIH/NIAMS, and on numerous boards for dermatology patient advocacy organizations. She has received several honors for her scholarship, leadership and mentorship, among them election to the American Association of Physicians and the American Dermatological Association, and awarding of the Stephen Rothman Award from the Society for Investigative Dermatology, Mentor of the Year, Rose Hirschler, and the Wilma Bergfeld, MD Visionary & Leadership awards from the Women’s Dermatological Society, the Clarence S. Livingood, MD Memorial Award from the AAD, the Founder’s Award from the Chicago Dermatological Society, the Tanioku Kihei Memorial Award from the Japanese Society for Investigative Dermatologist, and the inaugural Paula Stern Outstanding Women in Science and Medicine Award from Northwestern.
Webinar: Impostor Syndrome No More!
Join PeDRA for a very special webinar featuring Gail Gazelle, MD. Learn about the neuroscience of Imposter Syndrome, who it affects, why and how it develops, and practical strategies to leave it behind.
Presented by the PeDRA Early Investigator Committee
Imposter No More: Practical Strategies to Step into Full Authenticity and Confidence
Wednesday, February 23, 2022, at 4 PM PT / 7 PM ET
Gail Gazelle, MD, MCC
Dr. Gazelle is a former hospice physician, part-time Harvard Medical School Assistant Professor, and Master Certified Coach for physicians. Having coached over 500 physicians and physician leaders, Dr. Gazelle understands all of the challenges that healthcare presents, both during COVID and beyond.
A dynamic speaker known for her engaging, practical, and humorous style, Dr. Gazelle is a certified mindfulness meditation teacher and the author of the 2020 Everyday Resilience. A Practical Guide to Build Inner Strength and Weather Life’s Challenges and The Daily Dose of Calm, a free 14-day mindfulness series specifically for those in healthcare. She has a variety of free guides and meditations downloadable on her website. Her popular Charting Your Life workshop is available to hospitals and healthcare systems and will launch as a self-paced online charting efficiency course in early 2022.
Dr. Gazelle’s work has been featured in such diverse venues as the New England Journal of Medicine, the Journal of Physician Leadership, and O, the Oprah Magazine. Visit her website for more information.
Webinar: Blistering severe cutaneous adverse reactions in children: proposal for paediatric-focused clinical criteria
Blistering severe cutaneous adverse reactions in children: proposal for paediatric-focused clinical criteria
Blistering severe cutaneous adverse reaction in children: proposal for pediatric-focused clinical criteria. Dr. Michele Ramien summarizes a collaborative study on blistering severe cutaneous adverse reactions (SCAR) in children. It’s very important to diagnose these reactions early and accurately as they can be life-threatening. The study created categories that are more appropriate for diagnosing pediatric patients than what existed in the past. Watch to learn more about the impact on patients and next steps. Note to listeners: please turn up your volume.
Michele Ramien, MD
Dr. Ramien is a pediatric dermatologist and Associate Professor of Pediatrics at Alberta Children’s Hospital Research Institute.